Introduction
High-throughput screening of small molecule libraries, genetic reagents, and antibodies has been an indispensable tool for deciphering the mechanisms of disease and identifying potential therapeutics. Many diseases affect cell growth and division; therefore, assays of cell proliferation are especially important for highthroughput screening. High-throughput applications frequently employ end point assays that measure cell number by net metabolic activity (1, 2) , ATP content (3), or biomass (4) . These whole-well assays can be accurate in their reflection of cell number but do not directly measure any aspect of the cell cycle and cannot distinguish reduced growth rates from increased death. Since DNA replication in the S phase of the cell cycle is a prerequisite for mitosis, proliferative capacity can be inferred from DNA synthesis through measurements of labeled nucleotide incorporation.
Cells replicating their genomes readily incorporate either radioactive or nonradioactive nucleoside analogs into their nascent DNA. Autoradiography of cells labeled with [ 3 H]-thymidine provided early insights into the dynamics of DNA synthesis and cell proliferation in vivo (5) (6) (7) . Labeling cultured cells with [ 3 H]-thymidine allowed measurement of whole populations by scintillation counting (8) , making this a rapid and accurate assessment of proliferative capacity of homogeneous cell populations. The thymidine analog 5-bromo-2′-deoxyuridine (BrdU) is a nonradioactive nucleoside that can be used to measure DNA synthesis on a per-cell basis when detected by microscopy or flow cytometry (9) , allowing analysis of heterogeneous cell populations. Detection of incorporated BrdU requires both a monoclonal antibody and antigen retrieval by acid (9) , heat (10) , or nuclease treatment (11, 12) . Both immunodetection and enzymatic antigen retrieval are costly, while acid treatment can compromise other antigens, cell morphology, and reporter gene (e.g., GFP) function. A recently described chemical method of labeling DNA synthesis in cells and tissues uses the alkyne-substituted nucleoside 5-ethynyl-2′-deoxyuridine (EdU) as a reactive substrate for azide-substituted fluorescent dyes. During the copper-catalyzed alkyne azide cycloaddition (CuAAC or 'click') reaction, a covalent bond is formed between the alkyne base and the azide dye. This reaction is rapid, specific, and requires minimal sample processing (13) . We adapted this method without the use of commercial kits or custom reagents for use with 96-well plates on a high-throughput liquid handling platform. All experimental steps were automated, and the samples were processed in situ for analysis by automated quantitative fluorescence microscopy.
We chose MCF10A non-tumorigenic mammary epithelial cells as our model system because their proliferation can be manipulated by epidermal growth factor (EGF) and serum media supplements (14) (15) (16) (17) . We combined the chemical assay of DNA synthesis with measurement of DNA content to provide a more comprehensive cell cycle analysis. 4,6′-diamidinoAdaptation and validation of DNA synthesis detection by fluorescent dye derivatization for high-throughput screening Cellular proliferation is fundamental to organism development, tissue renewal, and diverse disease states such as cancer. In vitro measurement of proliferation by high-throughput screening allows rapid characterization of the effects of small-molecule or genetic treatments on primary and established cell lines. Current assays that directly measure the cell cycle are not amenable to high-throughput processing and analysis. Here we report the adaptation of the chemical method for detecting DNA synthesis by 5-ethynyl-2′-deoxyuridine (EdU) incorporation into both highthroughput liquid handling and high-content imaging analysis. We demonstrate that chemical detection of EdU incorporation is effective for high-resolution analysis and quantitation of DNA synthesis by high-content imaging. To validate this assay platform we used treatments of MCF10A cells with media supplements and pharmacological inhibitors that are known to affect cell proliferation. Treatments with specific kinase inhibitors indicate that EGF and serum stimulation employs both the mitogen extracellular kinase (MEK)/extracellular-regulated kinase (ERK) and phosphoinositol-3 kinase (PI3K)/AKT signaling networks. As described here, this method is fast, reliable, and inexpensive and yields robust data that can be easily interpreted.
Reports 2-phenylindole (DAPI) is a quantitative DNA stain that can be used to resolve the G 0 /G 1 , S, and G 2 /M phases of the cell cycle (18) and has been used previously to monitor cell cycle with highcontent imaging (19, 20 MCF10A cells growing in complete medium were labeled with a 2-h pulse of 10 µM EdU immediately prior to fixation. Fluorescent dye was covalently bound to the incorporated label using the CuAAC reaction to give Cy5-EdU. Images were collected with a Cellomics ArrayScan using the 20× objective and high-resolution CCD camera settings. DAPI-stained nuclei (A) and Cy5-EdU (B) are pseudocolored blue and red, respectively, in the composite (C).
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Innovation. To be continued.
BD patents the octagon detector array Upon ascorbate addition to the reaction, the mix became very unstable; maximal signalto-noise ratios were attained by keeping all reaction components separate until they were applied to the samples. Components were combined sequentially, mixing twice with each addition, and then applied to samples immediately. To facilitate multiplate processing, Tris-HCl and ascorbate solutions were maintained in bulk reservoirs, while CuSO 4 and Cy5-azide were dispensed into individual clean 96-well V-bottom plates (Corning Inc, Lowell, MA, USA) that also served as mixing vessels. The final reaction component concentrations were 100 mM Tris-HCl pH8.5, 4 mM CuSO 4 , 2 µM Cy5-azide, and 50 mM sodium ascorbate. Immediately after preparation, the reaction mix was dispensed into the 96-well tissue culture plate from which the PBS had been aspirated to a minimal volume. Reactions were allowed to proceed for 15-20 min in the dark and were stopped by rinsing with PBS. Residual Cy5 was destained from samples with PBS Tween (PBST)-BSA for at least 15 min, and then DNA was stained with 400 nM DAPI in PBST-BSA for 1 h at room temperature. Samples were washed with PBS and stored at 4°C until analysis.
BD Biosciences
High-content imaging
Plates were scanned with a Cellomics ArrayScan (Thermo Fischer Scientific) Figure 2 . The effects of EGF and serum starvation on DNA content and EdU incorporation in MCF10A cells. Complete medium was withdrawn from MCF10A cells and replaced with medium containing 0%, 0.1%, 0.5%, or 5% serum in the presence or absence of EGF (20 ng/mL). After 48 h in treatment media, cells were labeled with EdU and fixed. Samples were reacted with Cy5-azide using the CuAAC reaction, stained with DAPI, and analyzed by high-content imaging for total nuclear pixel intensity of DAPI and Cy5-EdU. Top panels show the frequency distribution of nuclear DAPI pixel intensity of cells treated with serum-free medium in the absence (A) or presence (B) of EGF. Middle panels show nuclear Cy5-EdU pixel intensity-expressed as a function of DAPI pixel intensity-of the same cells treated with serum-free medium in the absence (C) or presence (D) of EGF. A linear threshold for Cy5-EdU pixel intensity (1.2 × 10 4 ; dashed line in panels C and D) was used to quantify the sub-population of MCF10A cells with high levels of Cy5-EdU after serum and EGF treatments (E). Each treatment was analyzed in four independent wells, sampling at least 5000 cells per well. Error bars = 95% confidence interval.
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Reports automated epifluorescent microscope. Micrographs were acquired with the 10× objective and XF93 filter set. Data acquisition and analysis were controlled with the Cellomics Target Activation (v.3) application software, which maintained equivalent acquisition and processing parameters within each experiment. Exposure times were adjusted empirically to 25-35% of pixel intensity saturation. Nuclei were identified with the DAPI channel using a fixed pixel intensity threshold that was adjusted manually in each experiment to precisely delimit nuclear boundaries. Nuclei were segmented using the intensity peaks method with a setting of 4 or 5.
Background correction was applied by the surface-fitting method to both DAPI and Cy5 within a 150-pixel radius from each identified nucleus. Each nucleus was assayed for the total pixel intensity of DAPI and Cy5 fluorescence. Analysis was limited to four wells with ~5000 objects per well; Cy5-EdU-positive thresholds were set empirically according to the distribution of cells lacking Cy5 fluorescence.
Results and discussion
Here we describe the high-throughput application of an efficient assay that detects DNA synthesis by the formation of a covalent bond between a fluorescent dye and the incorporated nucleoside analog EdU. We found the method of Salic and Mitchison for EdU detection with the CuAAC reaction (13) to be very robust and highly sensitive without using kits or custom reagents. The assay repeatedly produced an excellent signalto-noise ratio with sub-nuclear resolution of DNA synthesis (Figure 1 ). During our experiments, reduction of the azide dye concentration below 2 µM resulted in decreased separation between the cells with and without incorporated label (data not shown). The CuAAC reaction mix, without the catalyst-generating ascorbate, was stable for up to 3 h at room temperature with only a modest decrease in total Cy5 intensity, while labeled and unlabeled nuclei could still be distinguished clearly (data not shown).
The quantitative DNA stain DAPI was used to measure DNA content of individual MCF10A cells grown for 48 h in serum-free medium with or without EGF (Figure 2, B and A, respectively) . In the absence of EGF, cells accumulated in G 0 /G 1 with a tight Gaussian distribution centered around a mean total DAPI pixel intensity of 1.6 × 10 4 (sd = 4.7 × 10 3 , n = 21,666; Figure 2A ). Cells grown with EGF showed a non-Gaussian distribution of nuclear DAPI intensities with S-phase and G 2 /M-phase populations (total DAPI pixel intensity > 2.1 × 10 4 ) representing 30% of the nuclei (n = 23,891; Figure 2B ) compared with 7% of the nuclei in cells grown without EGF (n = 21,666; Figure  2A ). DNA synthesis, detected by the incorporation of Cy5-EdU, was observed in 1.5% of cells grown in the absence of EGF ( Figure 2C ) but was readily detected in 23% of cells grown in the presence of EGF ( Figure 2D) . A threshold for Cy5-bright nuclei (Figure 2 , C and D, dashed line; total Cy5 pixel intensity > 1.2 × 10 4 ) was defined to identify nuclei with high levels of incorporated label and therefore positive for DNA synthesis. This S-phase population had a mean total DAPI pixel intensity of 2.6 × 10 4 (sd = 8.0 × 10 3 , n = 5563) representing DNA content intermediate to the respective 2n and 4n of G 0 /G 1 and G 2 /M. To test the contributions of serum to sustaining S phase, cells were grown for 48 h in serum concentrations of 0%, 0.1%, 0.5%, or 5% (v/v) with or without EGF ( Figure 2E ). DNA synthesis was assayed by EdU incorporation and, as above, Cy5-bright nuclei were identified as being positive for S phase. These data
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Innovation. To be continued. Reports show that EGF is a major contributor to the maintenance of S phase in MCF10A cells, although both EGF and complete 5% serum supplements were required to reach maximal rates of DNA synthesis.
To examine the intracellular signaling pathways required for progression into S phase, we used inhibitors of EGFR (AG1478), MEK (U0126 and PD98059), and PI3K (LY294002). MCF10A cells grown in complete medium were treated for 16 h with a dilution series of each inhibitor or DMSO vehicle control, and labeled with EdU as before. DNA content analysis showed effective cell cycle arrest in G 0 /G 1 by inhibition of EGFR or MEK with 0.6 µM AG1478 or 10 µM U0126, respectively ( Figure 3A) . The decrease in the S-phase and G 2 /M-phase populations observed by DNA content analysis is reflected in the EdU incorporation assay: these concentrations of AG1478 or U0126 reduced Cy5-EdU-positive cells by >97% relative to DMSO vehicle control cells ( Figure 3B ). The dilution series indicates AG1478 was the most potent inhibitor of DNA synthesis, efficiently suppressing EdU incorporation at all concentrations tested. U0126, the next most potent inhibitor, had an IC 50 of ~2 µM in this assay context. Inhibition of PI3K by LY294002 showed less dramatic reductions in DNA synthesis with an ~19% reduction in the S-phase population at 10 µM and an ~42% reduction at 20 µM relative to the DMSO vehicle controls ( Figure 3C ). The less effective MEK inhibitor, PD98059, showed only a modest effect at 20 µM ( Figure 3C ). The discrepancy between the two MEK inhibitors is not surprising, since the described in vitro IC 50 of U0126 is ~0.07 µM (MEK1/2), whereas the IC 50 of PD98059 is ~5 µM for MEK1 and ~50 µM for MEK2 (21) . These data indicate that EGFR and MEK activity are required for the maintenance of S phase while PI3K contributes substantially to this process.
Our quantitative assessment of S phase by EdU incorporation is consistent with previous studies of the requirements of EGF for MCF10A proliferation (14) (15) (16) (17) .
[ 3 H]-thymidine incorporation studies demonstrated that EGF is not the sole contributor to the proliferative capacity of MCF10A and that both serum and EGF are needed to reach the highest proliferation rates (16) . In a survey of breastderived cell lines, MCF10A cells treated with LY294002 or U0126 in complete medium showed reduced proliferation by indirect measurement of cell number at multiple time points (17) . The recapitulation of previous studies combined with the uniformity between DNA content and DNA synthesis data validate both this method of detecting DNA synthesis and the high-content imaging analysis platform. This does not, however, determine the suitability of these methods for screening applications.
To determine the robustness and sensitivity of this assay in the high-throughput screening context, we calculated the assay Z′-factor as described elsewhere (22) . Briefly, a Z′-factor of 0.1 <Z′ < 0.5 indicates a 'good' high-throughput screening assay while a Z′-factor of 0.5 < Z′ < 1 indicates an 'excellent' assay. For the calculation here, we used the opposing treatments (e.g., with and without EGF) as positive and negative controls. Z′-factors calculated from the EGF experiments indicate that Reports this assay is suitable for high-throughput screening at all three low-serum conditions: 0% serum, Z′ = 0.63; 0.5% serum, Z′ = 0.77; and 1% serum, Z′ = 0.51. Analysis of the inhibitor treatments under normal growth conditions yielded Z′ > 0.6 for all concentrations of U0126 and Z′ > 0.8 for all concentrations of AG1478. In contrast, LY294002 was marginally suitable for a high-throughput screening assay at 10 µM with Z′ = 0.16 but better at 20 µM with Z′ = 0.53. Together, these Z′-factor data indicate that the method described here not only provides an 'excellent' assay but can do so in various experimental contexts.
Assay miniaturization is a critical consideration for applying any method to the high-throughput screening context. We have successfully applied the labeling and chemistry described here in the 384-well format with essentially no modifications to the method. The smaller format reduces sample size, thereby reducing the statistical precision of population measurements. Assay sensitivity to sample size depends largely on the experimental context. For example, limiting the number of cells analyzed in the U0126 dilution series replicates to ~1100 reduced the assay Z′-factor such that the lowest concentration (0.6 µM) was no longer suitable for a high-throughput screening assay, 1.3 µM and 2.5 µM yielded Z′ = 0.3, while 5 µM, 10 µM, and 20 µM treatments retained Z′ > 0.5. Further reduction of the sample size to ~600 cells eliminated all but the highest U0126 treatments with Z′ = 0.3 for 5 µM and Z′ = 0.8 for 10 µM and 20 µM. From this data, we can speculate that a screen for escape from cell cycle arrest could be robustly assayed with a minimum of 500 cells, while detection of subtle changes in S phase or analysis of heterogeneous cells (e.g., transfections) would require a substantially larger sample size. Whatever the experimental context, the chemical method for DNA synthesis detection is highly specific, robust, sensitive, and very inexpensive (<$5 USD per plate), making this high-throughput assay an attractive method for high-content screening campaigns of small-molecule and genomic libraries.
